Company intelligence

CNMD

CONMED Corporation · NYSE · Healthcare

Price$51.13-0.70% · −$0.36

Market cap1.53BEquity value

P / E11.2Trailing ratio

Volume296.64KLatest session

Market data

CNMD price chart

TradingView

Related signals

1 min delayed

Browse public CNMD signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CNMDApr 25, 2024

Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say

- Conmed reported Q1 revenue of $312.27M, up 5.7% YoY with EPS of $0.79. - Revenue and EPS beat Zacks Consensus Estimates, with +1.70% and +6.76% surprises respectively. - Net Sales in Orthopedic and General Surgery segments increased year over year. - Shares of Conmed returned -7.5% over the past month, with Zacks Rank #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

CNMDApr 24, 2024-11.58% since signal

Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates

- Conmed reported earnings of $0.79 per share, beating estimates by 6.76%. - Revenues for the quarter ended March 2024 were $312.27 million, surpassing estimates by 1.70%. - Conmed shares have lost about 34.9% since the beginning of the year. - Management's commentary on earnings call will impact stock's immediate movement. - Estimate revisions for Conmed are mixed, currently a Zacks Rank #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

Research